[Chronic hepatitis--new therapeutic options]

Internist (Berl). 2001 Apr;42(4):516-22. doi: 10.1007/s001080050786.
[Article in German]
No abstract available

Publication types

  • Review

MeSH terms

  • Antiviral Agents / therapeutic use*
  • Contraindications
  • Drug Therapy, Combination
  • Hepacivirus / isolation & purification
  • Hepatitis B virus / isolation & purification
  • Hepatitis B, Chronic / drug therapy*
  • Hepatitis C, Chronic / drug therapy*
  • Humans
  • Interferon Type I / administration & dosage*
  • Interferon Type I / adverse effects
  • Interferon alpha-2
  • Interferon-alpha* / therapeutic use
  • Lamivudine / administration & dosage
  • Lamivudine / adverse effects
  • Polyethylene Glycols*
  • Practice Guidelines as Topic
  • Randomized Controlled Trials as Topic
  • Recombinant Proteins
  • Reverse Transcriptase Inhibitors / therapeutic use*
  • Ribavirin / administration & dosage
  • Ribavirin / adverse effects

Substances

  • Antiviral Agents
  • Interferon Type I
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Reverse Transcriptase Inhibitors
  • Lamivudine
  • Polyethylene Glycols
  • Ribavirin
  • peginterferon alfa-2b
  • peginterferon alfa-2a